Skip to content

Evaluating the effect of alvatan repair cream on the healing of erosions of patients with epidermolysis bullosa

Evaluating the effect of alvatan repair cream on the healing of erosions of patients with epidermolysis bullosa -Interventional - Clinical trial (no control group or non-randomized)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260428069199N1
Enrollment
15
Registered
2026-05-05
Start date
2026-05-05
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidermolysis bullosa. Epidermolysis bullosa

Interventions

Intervention group: Patients with epidermolysis bullosa over the age of 5 who are treated with Alvatan Repair Cream twice a day for 4 weeks, which is rubbed into the wound area until completely absorb

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of epidermolysis bullosa Their parents consented to participate in the study. Age over 5 years Presence of at least one measurable wound

Exclusion criteria

Exclusion criteria: Patients under 5 years of age Lack of consent from the patient or his/her parents to participate in the study Positive history of allergy to each of the drug components

Design outcomes

Primary

MeasureTime frame
Change in pruritus severity. Timepoint: week 0 and week 4. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Change in pain severity. Timepoint: week 0 and week 4. Method of measurement: Visual Analogue Scale.;Change in wound size (cm²). Timepoint: week 0 and week 4. Method of measurement: By measuring with a ruler with an accuracy of 1 mm.;Patient Global Impression of Improvement. Timepoint: week 4. Method of measurement: 7-point Likert scale.;Clinical Global Impression Improvement. Timepoint: week 4. Method of measurement: 7-point Likert scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMustafa Nasiri

Shiraz University of Medical Sciences

mostafakhormuji@gmail.com+98 71 3235 1087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026